EU Antitrust Raids Target AstraZeneca

Law360, New York (December 3, 2010, 2:06 PM EST) -- European antitrust regulators have raided the offices of AstraZeneca PLC, citing suspicions that the pharmaceutical company colluded with other drugmakers to keep generic versions of a drug off the shelves.

U.K.-based AstraZeneca told Law360 on Friday that the European Commission carried out unannounced inspections of a “small number” of its European offices on Nov. 30 related to its multibillion-dollar heartburn and ulcer treatment drug Nexium.

Switzerland-based Nycomed US Inc., which produces a similar drug called Pantozol, also confirmed that regulators had raided two of its offices...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.